polypropylene conical tubes for clarification via high-speed centrifugation at 10,000xg for 1 h. The synovial fluid supernatants were transferred to fresh polypropylene tubes and stored at -80°C. Clarified synovial fluid was thawed, pooled and purified using previously described methodology, 1 with some modifications. Equine synovial fluid was concentrated five-fold using 100kD molecular weight cut off centrifugal filter devices (Amicon® Ultra, Millipore, Tullagreen, Carrigtwohill, IRL) by centrifugation at 4,000xg, 4°C. The mucinous synovial fluid retentates were re-suspended in 50mM NaAc buffer, pH 5.5, with proteolytic inhibitors, to the original synovial fluid volume. Hyaluronic acid digestion was performed using Streptomyces hyaluronidase (Calbiochem®, EMD Chemicals, San Diego, CA) at a final concentration of 1U/mL of re-suspended synovial fluid at 4°C for 16 h on an end-over-end rocker. The hyaluronidasedigested synovial fluid samples were centrifuged at 4,000xg, 4°C for 5 minutes to pellet debris, and the supernatant was purified using a HiTrap TM diethylaminoethyl (DEAE) fast flow sepharose column (GE Healthcare Life Sciences, Little Chalfont, UK) for fast protein liquid chromatography (FPLC).
Lubricin was eluted from the DEAE column after rinsing with 50mM NaAc using a 200mM step-wise elution gradient from 200mM to 1M NaCl. Each 200mM fraction was loaded onto a 4-20% tris-glycine gradient gel (Bio-Rad, Hercules, CA) for reducing and non-reducing sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), followed by Coomassie staining (Teknova, Hollister, CA). The 400-600mM fraction with a single prominent band at >250kD
was dialyzed against phosphate buffered saline (PBS) with proteolytic inhibitors at 4°C for 36 h, with 3 exchanges of PBS. Immunoblotting of all FPLC-purified fractions was performed using a polyclonal antibody raised in rabbit and directed against the synthetic peptide CLPNIRKQPDGYDYYAFSKDQ corresponding to amino acids 1356-1374 of the C-terminus of human lubricin (ab28484, Lot:
GR116636-3, Abcam®, Cambridge, UK), in addition to the monoclonal antibody 9G3 raised in mouse and directed against the mucin domain of human lubricin (MABT401; EMD Millipore), which is highly conserved across species. Both antibodies were predicted to cross-react with equine lubricin based on sequence homology of the C-terminus and mucin-rich region of lubricin, and antibodies were validated in equine using synovial fluid as a positive control and serum as a negative control. The final protein concentration of lubricin fractions was quantitated using a bicinchoninic acid protein assay (Thermo Scientific, Rockford, IL) using bovine serum albumin as the standard and read out on a microplate reader (Tecan Safire, Mannedorf, Switzerland) at 562nm absorbance.
MALDI/TOF-MS Glycosylation Analysis of Synovial Fluid Lubricin
For lubricin glycosylation analysis, synovial fluid was aspirated in similar fashion from the carpal joints of a healthy 5-year old horse and clarified by centrifugation.
The >100kD synovial fluid retentate was digested at with 1U/mL of Streptomyces hyaluronidase in 50mM NaAc buffer, pH 5.5 with proteolytic inhibitors overnight at 4°C. Lubricin was purified using DEAE anion-exchange resin, rinsing with 350mM NaCl and eluting in 1M NaCl. The purified lubricin was de-salted overnight using a 50kD tube dialyzer (G-Biosciences, St. Louis, MO), followed by removal of fibronectin via gelatin separopore® 4B purification (Bioworld, Dublin, OH) and elution in ultrapure water. For mass spectrometry, the lubricin samples were dried and subjected to beta-elimination to cleave O-linked glycans. Olinked glycans were cleaved with NaOH and serine-linked GalNAc was reduced with NaBH4. The reaction was neutralized with acetic acid, desalted, and cleaned of borates prior to permethylation. O-linked glycans were permethylated for structural characterization by mass spectrometry, dissolved with methanol and crystallized with α-dihydroxybenzoic acid, 20mg/mL, in 50% methanol: water.
Glycan analysis was performed in the positive ion mode by MALDI-TOF/TOF-MS using AB SCIEX TOF/TOF 5800 (Applied Biosystems, Thermo-Scientific, Waltham, MA).
Lubricin and Galectin Cartilage Immunohistochemistry
Osteochondral blocks were harvested from the carpal bones of the middle carpal joint of a healthy 4-year old horse, fixed in 4% paraformaldehyde, de-calcified in 
Confocal and Multi-photon Imaging of Cartilage Explants
Articular cartilage biopsies were harvested from the medial femoral condyle of adult equine stifle joints using a 6mm biopsy punch (Miltex, York, PA) and immediately frozen at -80°C. For lectin imaging, cartilage explants were thawed to room temperature, rinsed in PBS and incubated for 1 hour at 4°C in 10ug/mL FITC-conjugated lectin (Vector Labs, Burlingame, CA), or Atto488-conjugated MAL-II lectin. MAL-II (Vector Labs) was conjugated with Atto488 in the presence of 150mM β-lactose. Explants were rinsed in PBS and stained with 1ug/mL Hoechst 33342 (Life, Thermo Scientific, Waltham, MA) for 20 minutes to stain chondrocyte nuclei, followed by several rinses in PBS. Explants were imaged in glass dishes (MatTek, Ashland, MA) using a Zeiss inverted laser scanning microscope with a 40X water immersion objective. For fluorescent galectin and/or lubricin staining, explants were first incubated for 1 hour at 4°C in 100mM β-lactose to extract endogenous galectins. Following re-equilibration in PBS, each explant was incubated in 10ug/mL of A647-labeled galectin-1 or galectin-3 in PBS for 1 hour at room temperature. As a control for non-specific binding, explants were also incubated with A647-labeled galectin-1 or galectin-3 in the presence of 300mM β-lactose. For lubricin staining, explants were incubated in 10ug/mL of A568-labeled anti-lubricin mAb (MABT401, EMD Millipore). To compare lubricin staining following β-lactose removal of galectins, explants were incubated in either PBS or PBS + 100mM β-lactose at 4°C for 12 hours, followed by 3 rinses in PBS, incubation in 10ug/mL of A568-labeled anti-lubricin mAb for 1 hour, and Hoechst staining. Explants were rinsed in PBS, and z-stacks were obtained for four regions of interest on five separate explants for quantitation. All experiments were performed in triplicate.
Cloning, Expression and Purification of Galectins Human galectin-1, galectin-3 and galectin-3C
The N-terminal truncation mutant, Gal-3C, was made through PCR amplification of a human Gal3 template with forward (5'-GGCAGGATCCTACCCTGGAGCACCTGGAGCTTATC -3') and reverse (5'-GGCAGCGGCCGCTTATATCATGGTATATGAAGCACTG-3') primers that introduced 5' BamHI and 3' NotI restriction sites for cloning into pET21a.
Recombinant human galectin-1 and galectin-3 constructs were obtained from C.
Bertozzi and, along with the galectin-3C mutant, were expressed in XL1-Blue competent E. coli. Recombinant galectins were purified using β-lactosyl sepharose affinity chromatography similar to previously described methods 2 .
Briefly, Sepharose® 6B (Sigma-Aldrich, St. Louis, MO) was activated with 40% divinyl sulfone prepared in 0.5M Na2CO3, pH 11.0, followed by washing with 
Equine galectin-1 and galectin-3
cDNA was isolated from kidney tissue harvested from a 19-year-old Thoroughbred mare following euthanatization. RNA was purified following renal tissue homogenization and lysis with Proteinase K (PerfectPure, 5PRIME, Gaithersburg, MD), followed by cDNA synthesis (SuperScript® First-Strand Synthesis, Invitrogen, Carlsbad, CA).
Gene-specific primers were designed against the predicted sequences of equine galectin-1 and galectin-3 from the National Center for Biotechnology Information (NCBI), with the equine galectin-1 forward primer designed to begin at nucleotide (nt) 292 of the predicted equine sequence based upon sequence homology between the human homologue, translated as MACGLVASNLNKPGECL and the fact that the predicted equine galectin-1 mRNA sequence was 292bp longer than the human homologue. Thus, the galectin primers were designed as follows: 
Measurement of Lubricin Galectin Binding Kinetics Biotinylation of equine galectins
Recombinant equine galectin-1 and -3 were biotinylated in the presence of 
Colorimetric plate assay
Lubricin purified from normal equine synovial fluid or bovine asialofetuin (SigmaAldrich, St. Louis, MO) was coated to high-binding, 96-well ELISA plates (Corning Inc., Corning, NY) in sodium carbonate buffer, pH 9.6, at 4°C and at a final concentration of 4ug/mL. After incubation for 16 hours, wells were aspirated and rinsed in PBS plus 0.1% Tween, followed by blocking with Pierce® ProteinFree (PBS) Blocking Buffer (Thermo Scientific, Rockford, IL). Recombinant, biotinylated equine galectin-1 or galectin-3 was added to each well in duplicate at concentrations ranging from 0.078ug/mL to 5ug/mL in PBS-T (0.1%) for 1hr at room temperature, with and without β-lactose (Santa Cruz Biotechnologies, Santa Cruz, CA) at concentrations of 50, 150 or 500mM. After aspiration and rinsing in PBS-T (0.1%), high-sensitivity streptavidin-HRP (Thermo Scientific, Rockford, IL) was added at a 1:10,000 dilution in PBS-T (0.1%) for 30 minutes, followed by a final aspiration and rinse in PBS-T (0.1%). Finally, trimethylbenzidine reagent (Pierce, Rockford, IL) was added for 10 minutes, the reaction was stopped with 2N H2SO4, and absorbance was measured at 450nm with 540nm subtraction. Binding assays were performed similarly for FPLCpurified equine synovial fluid lubricin digested with Sialidase A TM (Glyko).
Enzymatic reactions
Buffer exchange of FPLC-purified equine synovial fluid lubricin into ultrapure water was performed using spin desalting columns (Zeba TM , Thermo Scientific, Rockford, IL), followed by concentration to 1mg/mL with 100K molecular weight cut off centrifugal filter devices (Amicon® Ultra, Millipore, Tullagreen, Carrigtwohill, IRL). Concentrated, buffer-exchanged purified lubricin was digested with the following combinations of deglycosylation enzymes: i) N-
Acetylglucosaminidase) (PROzyme®, Glyko®, Hayward, CA) listed in S1 Table. Deglycosylation reactions were carried out according to the non-denaturing protocol in the manufacturer's instructions, using 50μg of lubricin per reaction in the presence of 0.25M sodium phosphate, pH 7.0 at 37°C for 16 hrs.
Electrophoresis and SYPRO staining
Following deglycosylation, 5ug (10uL) of native lubricin and each lubricin reaction were resolved on a NuPAGE® Novex® 3-8% Tris-Acetate gel under denaturing conditions. Bands were detected using fluorescent SYPRO® Ruby gel stain and compared to HiMark TM pre-stained high molecular weight standards (Invitrogen, Carlsbad, CA) to assess the extent of deglycosylation.
Cartilage Tribometry
groove of young bovine stifles and stored in PBS at -20°C prior to tribological testing. After thawing to room temperature, cylindrical samples (6 mm diameter by 2 mm high) were incubated in sterile PBS or recombinant human galectin-1, galectin-3, or galectin-3C at a concentration of 50μg/mL for 1 h. Cartilage samples were submerged in a bath of PBS or galectin for tribological testing using a custom friction apparatus. This testing method has been previously described 3 . Briefly, the friction apparatus linearly oscillated each sample against a glass counterface three times at a controlled speed of 0.32mm/sec after allowing the cartilage sample to relax for 1 hour under an applied normal strain of 30%. Custom Matlab code (The Mathworks, Natick, MA) was used to calculate the mean equilibrium frictional coefficient (μeq) based on the final two oscillations.
Tribometry data were compared using 2-sample student's t-tests with p < 0.05 considered significant, and all values are reported as mean ± SEM.
Results

Purification of Synovial Fluid Lubricin
Coomassie staining of equine diethlyaminoethyl (DEAE) FPLC-purified synovial fluid fractions subjected to SDS-PAGE on a 4-20% tris-glycine gel revealed a single, prominent protein band at >250kD for the 400-600mM fraction, consistent with equine lubricin (S1 Fig A) . Faint bands were present at ~70kD and 25kD, and immunoblotting with a C-terminal lubricin antibody (ab28484, Abcam)
showed reactivity with the >250kD, 70kD and 25kD bands (S1 Fig B) . Similar Table. Enzymes used to deglycosylate equine synovial fluid lubricin. β-N-Acetylglucosaminidase Removes glycans (e.g. polylactosamines)
